ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 52 filers reported holding ODONATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 37.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $6,000 | -25.0% | 1,959 | -16.1% | 0.00% | – |
| Q2 2021 | $8,000 | -98.8% | 2,334 | -98.8% | 0.00% | – |
| Q1 2021 | $651,000 | +289.8% | 190,244 | +2088.2% | 0.00% | – |
| Q4 2020 | $167,000 | +1418.2% | 8,694 | +969.4% | 0.00% | – |
| Q3 2020 | $11,000 | -98.7% | 813 | -95.9% | 0.00% | -100.0% |
| Q2 2020 | $841,000 | +992.2% | 19,854 | +609.8% | 0.00% | – |
| Q1 2020 | $77,000 | -1.3% | 2,797 | +16.6% | 0.00% | – |
| Q4 2019 | $78,000 | +178.6% | 2,398 | +126.4% | 0.00% | – |
| Q3 2019 | $28,000 | -65.0% | 1,059 | -51.2% | 0.00% | – |
| Q2 2019 | $80,000 | +95.1% | 2,170 | +17.9% | 0.00% | – |
| Q1 2019 | $41,000 | +64.0% | 1,840 | +2.9% | 0.00% | – |
| Q4 2018 | $25,000 | -30.6% | 1,788 | -4.0% | 0.00% | – |
| Q3 2018 | $36,000 | +63.6% | 1,862 | +90.8% | 0.00% | – |
| Q2 2018 | $22,000 | +15.8% | 976 | +9.7% | 0.00% | – |
| Q1 2018 | $19,000 | – | 890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,207,086 | $5,553,000 | 0.28% |
| Samsara BioCapital, LLC | 700,421 | $925,000 | 0.23% |
| Hennion & Walsh Asset Management, Inc. | 69,264 | $91,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 384,995 | $506,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 43,752 | $58,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,000 | $2,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 47 | $0 | 0.00% |
| BESSEMER GROUP INC | 230 | $0 | 0.00% |